Sage Journals: Discover world-class research

Abstract

Background

Adherence to a Mediterranean Diet (MeD) has been associated with lower disease severity in patients with psoriasis. However, the mechanism behind how this diet may lead to disease modification remain understudied. Recent studies have revealed dysbiosis of the gut microbiome in patients with psoriasis suggestive of inflammation and altered immune regulation. Diet affects the gut microbiome and this review aims to evaluate whether correcting this dysbiosis may be one theoretical mechanism by which the MeD may be associated with lower psoriasis severity.

Methods

A literature search of the PubMed database was conducted for the terms 1) ‘psoriasis’ and ‘microbiome’ or ‘microbiota,’ and 2) ‘Mediterranean diet’ and ‘microbiome’ or ‘microbiota’ with manual screening for relevant articles. In total, we identified 9 relevant primary research studies investigating the gut microbiome in patients with psoriasis and 16 relevant primary research studies investigating changes in the microbiota for those consuming a MeD.

Results

Though varying in exact levels of certain bacteria, studies analyzing the microbiome in psoriasis revealed dysbiosis. Those analyzing the effect of the Mediterranean diet on the microbiome revealed beneficial changes, including alleviating some of the same alterations seen in the microbiome of those with psoriasis.

Conclusion

Microbiota change is a possible mechanism why the MeD has previously been associated with lower psoriasis severity.

Keywords

psoriasis microbiome mediterranean diet dysbiosis psoriasis area and severity index lifestyle modification diet

Introduction

Psoriasis is a chronic inflammatory skin disorder, affecting 2%–4% of the Western population with incidence continuing to increase.^1,2 Psoriasis affects more than just skin, and is associated with co-morbidities such as cardiovascular disease, metabolic syndrome, and psoriatic arthritis¹

While there have been exciting developments in medical treatments for psoriasis, the effects of lifestyle factors remains understudied. Lifestyle modification, especially dietary changes, is of interest to patients.³ Studies show that most patients living with psoriasis have tried dietary changes in an attempt to control their disease.⁴

One diet of interest is the Mediterranean diet (MeD) due to its anti-inflammatory effects.⁵ The MeD focuses on increased consumption of nutrient and anti-oxidant rich foods such as vegetables, olive oil, and legumes while limiting meat and dairy.⁶ The diet has been widely studied with benefits such as improved cardiometabolic health and slowed cognitive decline.^5,6 In the few studies examining psoriasis and the MeD, results suggest the diet may be helpful in reducing psoriasis severity.⁷ For instance, a cohort study of 3557 psoriasis patients found that dietary patterns more consistent with the MeD were associated with a lower psoriasis severity.⁸ Given the MeD’s many benefits, efforts have been made to determine by what physiologic mechanism the MeD causes its positive impact.⁶ Its effect on the gut microbiome is one mechanism that has been explored.

The gut microbiome is a population of microbes in the gastrointestinal tract, which impact metabolism and immune functioning.⁹ While the gut microbiome’s existence has been known for many years, its association with disease and ability to be manipulated for better health outcomes is an exciting area of interest. The consumption of different foods alters the gut microbiome, with some microbiota associated with good health, and others associated with pro-inflammatory effects potentially leading to obesity and insulin resistance.⁹

When discussing the microbiome, one should be familiar with the concepts of alpha- and beta-diversity, microbial diversity, microbial richness, and bacterial taxonomy. Microbial richness can be described as the number of taxa while microbial diversity is the different types of taxa. Alpha-diversity encompasses abundance, while beta-diversity is the variability in the identity of taxa within that community.¹⁰ The taxonomic classifications of bacteria are important as changes can occur at any of these levels (Figure 1).

Figure 1.

An example of bacterial taxonomy in the gut.¹¹

In this review, we evaluate what is known about the gut microbiome in patients with psoriasis and in those who follow a MeD. We also propose that changes in gut microbiota induced by a MeD as a theoretical mechanism for why the diet is associated with lower disease severity.

Methods

A literature search of the PubMed database was conducted for the terms 1) ‘psoriasis’ and ‘microbiome’ or ‘microbiota, ’ and 2) ‘Mediterranean diet’ and ‘microbiome’ or ‘microbiota’ Our search was limited to English-language articles and those published prior to August 11th, 2023. For review, the authors manually identified relevant articles discussing the gut microbiome and psoriasis or the MeD specifically. Duplicate articles were excluded. In total, we identified 9 relevant primary research studies investigating the gut microbiome in patients with psoriasis and 16 relevant primary research studies investigating changes in the microbiota for those consuming a MeD as the study group.

On September 8^th, 2023, our literature search was updated to include an article published August 31^st, 2023.

Results

The Gut Microbiome in Patients With Psoriasis

One of the earlier studies to explore the microbiome in patients with psoriasis was conducted by Scher et al in 2015. They found that patients with psoriasis and PsA had lower relative abundance of multiple intestinal bacteria (reduced diversity) compared to healthy controls.¹² Their findings are summarized in Table 1. It is accepted in other fields that low diversity in the microbiota is correlated with disease and reduced ability to cope with bodily insults.¹³ Additional studies (Table 1) revealed conflicting results surrounding diversity, with two studies confirming reduced diversity in psoriasis patients, five with no significant difference, and one finding increased diversity in their psoriasis cohort.^12–20

Table 1.

Complete Differences Across Studies Evaluating the Gut Microbiome in Patients With Psoriasis Separated by Taxonomic Groupings. A “-“ Indicates No Significant Findings in That Taxonomic Grouping for the Study, or the Study Did Not Perform Analysis Within That Grouping. F/B = Firmicutes/Bacteroidetes Ratio. Pso = Psoriasis. PsA = Psoriatic Arthritis. HC = Healthy Control.

Authors	Cohort	Methods	Psoriasis Microbiome: Diversity	Psoriasis Microbiome: Phyla	Psoriasis Microbiome: Class/Family	Psoriasis Microbiome: Genera	Psoriasis Microbiome: Species
Chang et al. 2022	United States	shotgun metagenomic sequencing	Not significantly different	—	—	—	↑Bacteroides coprocola
	Pso (n = 33)						↑Bacteroides oleiciplenus
	Age and gender matched controls (n=15)						↑Bacteroides vulgatus
							↑Clostridum hylemonae
							↑Prevotella disiens
							↑Parabacteroides goldsteinii
							↓Bifidobacterium psseudocatenulatum
							↓Bacteroides gallinarum

Chen et al. 2018	Asian, Taiwan	16s rRNA sequencing (hypervaria-ble region V4–V4)	Not significantly different	↑Firmicutes and ↓Bacteroidetes → ↑ F/B ratio	—	—	↓Akkermansia spp.
	Pso (n = 32)
	Age, gender, BMI, and geography matched controls (n = 64)
Codoner et al. 2018	Spain	16s rRNA sequencing (hypervariable region V3–V4)	↑ Diversity	—	—	↑Faecalibact-erium	↑Akkermansia spp
	PsO with PASI >6 (n = 52)					↑Ruminococ-cus	↓Faecalibacterium prausnitzii
	Controls (n = 300) from Human Microbiome Project					↓Bacteroides
Dei-Cas et al. 2020	Caucasian, Argentina	16s rRNA sequencing (hypervariable region V4)	Not significantly different	↑Firmicutes and ↓Bacteroidetes → ↑ F/B ratio	—	↑Blautia	—
	Pso (n=55; 28 mild disease; 27 mod-severe)	PMI validity: ROC Analysis;				↑Faecalibacterium
	Age, gender, BMI, geography matched controls (n = 27)	Meta-analysis Hildago-Cantabrana et al. dataset				↓Paraprevotella
Hidalgo-Cantabrana et al. 2019	Spain	16s rRNA sequencing (hypervariable region V2–V3)	↓ Diversity	↑Actinobacteria	↑Ruminococcaceae family	Within Ruminococcaceae family:	—
	Pso (n = 19)			↑Firmicutes and ↓Bacteroidetes → ↑ F/B ratio		↑ Ruminococcus
	Age and geography matched controls (n = 20)			↓Proteobacteria		↑Subdoligraanulum
						↓Faecalibactrium
						Others:
						↑Bifidobactrium
						↑Blautia
						↑Collinsella
						↑Slackia
						↓Alistipes
						↓Bacteroides
						↓ Barnesiella
						↓Parabacteroides
						↓Paraprevotella
Schade et al. 2021	Brazil	Massive 16S rRNA sequencing	↓ Diversity	—	—	↑Dialister	↑ Prevotella copri
	Pso (n = 21)					↑Catenilbacterium	↓Akkermansia spp.
	Age, BMI, gender, smoking status, comorbidity matched controls (n = 24)					↓Blautia
						↓Lachnospira
						↓Ruminococcus
Scher et al. 2015	USA
	PsA (n = 16), Pso (n = 15), Age, sex, and ethnicity matched controls (n = 17)	16s rRNA sequencing (hypervariable region V1-V2)	↓ Diversity v. HC	Pso v. PsA:	—	Pso v. PsA:
				→ ↑ F/B ratio		↓Coprobacillus
						PsA v. HC
	-					↓Akkermansia
						↓Ruminococcus,
						↓Pseudobutyrivibrio
						↓Parabacteroides
						↓ Alistipes
						↓Coprococcus
Shapiro et al. 2019	Israel	16s rRNA sequencing (hypervariable region V4)	Not significantly different	↑Actinobacteria	—	↑Blautia	↑Collinsella aerofaciens
	Pso (n = 24)			↑Firmicutes and ↓Bacteroidetes → ↑ F/B ratio		↑Faecalibacterium	↑Dorea formicigeneran
	Age, gender, and comorbidity matched controls (n = 22)			↓Proteobacteria		↓Prevotella	↑Ruminoccocus gnavus
							↓Prevotella copri

Tan et al. 2017	China	16s rRNA sequencing (hypervariable region V4)	↓ Diversity*	↓Tenericutes	—	↑Bacteroides	↑Clostridium citroniae
	Pso (n = 14)			↓Verrucomicrobia		↑Enterococcus	↓Akkermansia muciniphila
	Gender matched controls (n = 14)					↓Akkermansia
Zang et al. 2023	FinnGen database R8	16s rRNA sequencing and Mendellian randomization	N/A	Protective Against Pso: Bacteroidetes	—	Protective Against Pso: Prevotella	—
	Pso (n = 8075)					Causative for Pso: Eubacterium fissicatena
	Controls (n = 339,050)

As seen in the cladogram in Figure 1, taxonomic categorization of bacteria begins at the phylum and is followed by class.¹¹ At the phyla level, the human gut microbiome is composed primarily of the Firmicutes and Bacteroidetes. High levels of Firmicutes compared to Bacteroidetes (increased F/B ratio) has been correlated with greater BMI and higher levels of inflammatory markers.^21,22 In a 2018 Taiwanese study by Chen et al, researchers found an increased Firmicutes and decreased Bacteroidetes phyla in psoriasis patients when compared to age, gender, BMI, and geography matched controls, leading to an increased F/B ratio. Increased F/B ratios in psoriasis patients were found in three additional studies: a Caucasian cohort (n = 55) evaluated by Dei-Cas et al, Spanish psoriasis patients (n = 19) evaluated by Hidalgo-Cantabrana et al, and a cohort from Israel (n = 24) evaluated by Shapiro et al.¹⁸ Short chain fatty acids (SCFAs) such as butyrate are produced by some bacteria and have been suggested to promote epithelial integrity and exert an anti-inflammatory effect.²³ A higher F/B ratio leads to altered SCFA production – including decreasing butyrate - potentially explaining the negative metabolic associations.²⁴ Interestingly, there was a reduction in the Bacteroidetes phylum found in the 2015 study by Scher et al¹²’s study in psoriasis patients vs those with psoriatic arthritis, presumably raising the F/B ratio, though this was not commented on specifically and this finding did not reach significance. The most recent study on the gut microbiome in psoriasis performed mendelian randomization on published large-scale genome wide association studies comparing greater than 10000 patients with psoriasis to healthy controls. They found that Bacteroidetes have a protective role in psoriasis (OR .81 [95% CI .67-.98]), further supporting the findings of low Bacteroidetes in psoriasis patients from previous studies.²⁵

The next level of taxonomy is the genera level. In terms of significant findings for Scher at al., Parabacteroides genus was reduced compared to healthy controls which was replicated in one other study.^12,17 Tan et al sequenced the microbiome in a Chinese cohort (n = 14) finding several significant changes, including an increase in the Bacteroides genus and decrease in the Akkermansia genus including the Akkermansia muciniphila species. Higher Bacteroides is typically seen in animal-based diets, and though some species in the genus have beneficial properties, an overgrowth can degrade important intestinal mucus leading to intestinal inflammation and is associated with colonic cancer.²⁶ Bacteroides can also be thought of in the context of the Prevotella/Bacteroides (P/B) ratio, where a high ratio (lower Bacteroides) is associated with improved metabolic status.²⁷ Decreases in Akkermansia muciniphila are associated with chronic inflammatory states including obesity.¹⁹ This decrease in the Akkermansia genus was replicated in a cohort of psoriasis patients (n = 32) in Taiwan and another cohort (n = 21) from Brazil.^13,15 However, other studies have challenged these findings with Codoner et al finding an increase in the Akkermansia genus and a decrease in the Bacteroides genus in their cohort of 52 psoriasis patients from Spain when compared to unmatched controls (n = 300) from the Human Microbiome Project. This decrease in Bacteroides was also seen in a separate cohort from Spain (n = 19) compared to age and geography matched controls.¹⁷ These differences between studies may be due to the differences in severity of psoriasis, matching protocols used for controls, and geography of the study populations particularly considering both cohorts with a decrease in the Bacteroides genus were from Spain whereas 2/3 studies that found an Akkermansia genus decrease evaluated East Asian patients. Another consistency across both the studies out of Spain was increased Blautia genus in the psoriasis groups.^14,17 However, despite analyzing the microbiome of patients from the same country of Spain, Codoner et al and Hidalgo-Cantabrana et al did have some conflicting findings, with Codoner et al finding increased Faecalibacterium genus which was supported by an additional study, while Hidalgo et al found a decrease in psoriasis patients.^14,16,17 From the mendelian randomization study, the genus Prevotella was found to possibly have a protective impact (OR .87 [95% CI: .76-1.00] whereas Eubacterium fissicatena conferred an increase risk for psoriasis (OR 1.22 [95% CI: 1.10-1.35]).²⁵ The Prevotella genus was found to be decreased in a psoriasis cohort in a study that took place in Israel.¹⁸ In the same family as Prevotella, the genus Paraprevotella was found to be decreased in two studies.^13,17

Within genera, there are a few species of particular interest such as the discussed Akkermansia muciniphila species. Similarly, within the Faecalibacterium genus, one notable species is Faecalibacterium prausnitzii. Which is one of the main butyrate producers in the colon and its presence is reduced in inflammatory intestinal disorders.²⁸ In their study, Codoner et al found that although the Faecalibacterium genus was increased in their psoriasis cohort, F prausnitzii was actually reduced.¹⁶ Hidalgo-Cantabrana et al did not report to the species level, though presumably F prausnitzii was reduced given the genus was reduced as a whole.¹⁴ Prevotella copri is a member of the Prevotella genus, and two studies had conflicting significant results regarding levels in psoriasis patients.^13,18 This species is associated with high fiber, low fat diets and often linked with desirable health, although conflicting reports exist.²⁹

The Gut Microbiome in Patients Consuming a Mediterranean Diet

Research on the effects of the Mediterranean diet on the gut microbiome can similarly be classified by taxonomic class. Of the studies that included results on diversity, 8 found no change, while 6 found increased diversity and/or richness (Table 2).^21,30–41 Studies that showed no change in microbiota were shorter duration (4-7 days) with less time for adherence, suggesting that to achieve a meaningful, anti-inflammatory change in one’s microbiome, following the MeD for a longer timeframe leads to a greater likelihood of benefitting.^33,40 Others researched the effects on diversity more intricately, such as van Soest et al²¹ who showed that increased alpha diversity was positively correlated with peanuts, seeds, nuts, and fresh fruit and negatively correlated with BMI. Some studies also chose to research the effects of the MeD on bacterial richness rather than diversity and found that richness was either increased or maintained.^30,42

Table 2.

Complete Differences Across Studies Evaluating the Gut Microbiome in Patients Following the Mediterranean Diet and Other Lifestyle Interventions. Changes in Microbiota Separated by Taxonomic Groupings. A “-“ Indicates No Significant Findings in That Taxonomic Grouping for the Study, or the Study Did Not Perform Analysis Within That Grouping. F/B = Firmicutes/Bacteroidetes Ratio. Pso = Psoriasis. WD = Western Diet. MD = Mediterranean Diet. FF = Fast Food. BMI = Body Mass Index. MetS-OB = Metabolic Syndrome and Obesity. NAFLD = non-alcoholic Fatty Liver Disease. VD = Vegetarian Diet. HIV = Human Immunodeficiency Virus.

Authors	Cohort	Methods	Bacterial Changes: Diversity	Bacterial Changes: Phyla	Bacterial Changes: Class/Family	Bacterial Changes: Genera	Bacterial Changes: Species
Barber et al. 2021	-20 healthy men	MetaPhlAn 2.0 (v2.9.14) and HUMAnN 2.0 (v2.9.0)?	Increase in beta diversity in FMD compared to western diet	—	—	MD: ↑Agathobaculum	MD:↑Agathobaculum butyriciproducens↑Anaerostipes hadrus
Barber et al. 2021	-a 2-week washout period followed by 2-weeks of each diet, Western-type diet and fiber-enhanced MD	-axonomic identification relies on clade-specific marker genes included in the “v296_ChocoPhlAn_201901” database		—	—	↑Anaerostipes	MD:↑Agathobaculum butyriciproducens↑Anaerostipes hadrus
Calabrese et al. 2022	-109 patients with NAFLD-randomized to six different groups based on diet, exercise, and diet and exercise combined	-16S rRNA hypervariable V3 and V4 regions	No significant difference on alpha diversity	—	—	MD+aerobic exercise:	—
						↑Akkermansia
						↑Alistipes
						↑Dialister
						↑Eubacterium eligens
						↑Oscillospiraceae-UCG002
						↑Oscillospiraceae-UCG005
						↑Ruminococcus
						↑Tyzzerella
						↑uncultured_Peptococcaceae
						↓Collinsella
Forteza et al. 2022	-7 adult, active women with no metabolic conditions	-16S rRNA amplification V3 and V4 regions	No significant difference	—	MD: ↑Oscillospiraceae family	—	—
	-compared effect of 7-day MD diet versus Canadian macronutrient diet				↑Prevotellaceae family
	-16S				↓Coriobacteriaceae family↓Erysipelotrichaceae family
Gomez-Perez et al. 2023	-297 overweight/obese patients with NAFLD-participants consumed energy-reduced MD or unrestricted MD for 1 year	-16S rRNA primer set V2–4–8 and primer set V3–6, 7–9	Beta diversity changed in T1 and T2 Alpha diversity changed only in T1	↓Lentisphaerae↓Proteobacteria	↑Alcaligenaceae family↑Bifidobacteriaceae family↓Enterobacteriaceae family	↑Bifidobacterium	—
						↑Coprococcus
						↑Desulfovibrio
						↑Faecalibacterium
						↑Lachnospira
						↑Oscillospira
						↑Sutterella
Gosh et al. 2020	-612 elderly patients of European decent consuming MD for 12—months	-16S rRNA amplification V3 and V4 regions	No significant difference in MD intervention groups	—	—	—	↑Anaerostipes hadrus
							↑Bacteroides thetaiotaomicron
							↑Faecalibacterium prausnitzii
							↑Eubacterium. eligens
							↑Eubacterium rectale
							↑Eubacterium xylanophilum
							↑Prevotella copri
							↑Roseburia hominis
Haro et al. 2017	-106 subjects, 3 study groups: obese with metabolic disease, obese without metabolic disease, and not obese -participants consumed MD diet for 2-years	-16S rRNA V4 515–806 bp region	No significant difference	MD in MetS-OB ↑Bacteroidetes*	—	MD in MetS-OB: ↑Bacteroides↑Faecalibacterium↑Prevotella↑Roseburia↑Ruminococcus genus	MD in MetS-OB:↑Parabacteroides distasonis↑Prausnitzii
Haro et al. 2017		-16S rRNA V4 515–806 bp region	No significant difference	→ ↓ F/B ratio	—		MD in MetS-OB:↑Parabacteroides distasonis↑Prausnitzii
Illescas et al. 2021	-meta-analysis of public 16S data from people following MD or other diets	-16S rRNA meta-analysis search	No significant difference in alpha diversity	MD: ↑ Verrucomicrobia ↓Candidatus Saccharibacteria↓ Proteobacteria MD vs. WD: ↓Euryarchaeota↓Fusobacteria↓Firmicutes↑Bacteroidetes→ ↓ F/B ratio	MD: ↑Ruminococcaceae family↑Veillonellaceae family↓Helicobacteraceae family↓Sphingomonadaceae family	MD: ↑Adlercreutzia↑Akkermansia↑Bifidobacterium↑Coprococcus↑Dialister↑Dorea↑Slackia genus↓ Lachnospiraceae	-MD: ↓Fusobacterium nucleatum↓Methanobrevibacter smithii
Illescas et al. 2021		-16S rRNA meta-analysis search	Significant difference beta-diversity in MD group compared to other study groups
Ismael et al. 2021	-9 patients with T2DM-received counseling on the MD over 12 weeks-16S rRNA	-16S rRNA region V3–V4	No significant difference	-MD at 12 weeks:↑Bacteroidetes phylum↓Firmicutes phylum→ ↓ F/B ratio	—	-MD at 4 weeks: ↑Prevotella↓Bacteroides	—
Meslier et al. 2020	-82 overweight and obese people over an 8-week period-39 continued their regular diets-43 consumed a MD with the first 4 weeks being high-adherence	-16S rRNA region V3–V4	Diversity not measured	—	—	Baseline to 8 weeks:↑Lachnospiraceae↑Roseburia	↑Faecalibacterium prausnitziiBaseline to 4 weeks:↓Flavonifractor plautii↓Ruminococcus gnavus↓Ruminococcus torques↓Ruthenibacterium lactatiformans↓Streptococcus thermophilus
Pagliai et al. 2019	-23 overweight omnivores with -randomly assigned to VD or MD for 3-month period	-16S rRNA region V3–V4	No significant difference in alpha diversity.	—	—	MD: ↑Enterorhabdus↑Lachnoclostridium↓Parabacteroides	—
Pastor-Ibanez et al. 2021	-102 HIV positive individuals-received supplemented MD or control diet for 12 weeks	-16S rRNA region V3–V4	No significant difference in alpha or beta diversity in intervention group	—	—	high-adherence supplemented MD:↑Burkholderiales↑Butyrivibrio↑Catenibacterium↑Succinivibriolow-adherence:↑Bacteroides↑Bilophila↑Desulfovibrio↑Parabacteroides↑Paraprevotella high adherence: ↓Bacteroides	—
Rinott et al. 2022	-294 people with obesity/dyslipidemia-Patient randomized 1:1:1 to healthy diet, MD, or green MD for 6 months	-16S rRNA region V3–V4	Diversity not measured	—	—	-green MD and MD:↑Bacteroides↑Enterorhabdus↑LachnospiraMD:↑Erysipelotrichaceae↑Gemella↑Granculicatellagreen MD:↑Lachnospiraceae↓Collinsella↓Dorea↓Ruminococcaceae	—
Tagliamonte et al. 2021	-82 overweight and obese people over an 8-week period-39 continued regular diet-43 consumed a MD	-amplified using primers target-ing the 16S rRNA for A. muciniphila	Diversity not measured	-	-		↑Akkermansia muciniphila↑Faecalibacterium prausnitzii↑Roseburia faecis↑Roseburia hominis
Van Soest et al. 2020	-252 healthy older adults-received counseling on MD over a year-16S rRNA	-16S rRNA V1 and V6 hypervariable regions	Alpha diversity positively correlated with peanuts, nuts, seeds, fresh fruit, vitamin C, plant protein. Alpha diversity negatively correlated with BMI	Fresh fruits, vitamin C, and nuts, seeds and peanuts↑ Bacteroidetes→ ↓ F/B ratio	—	Fresh fruits, vitamin C, and nuts, seeds and peanuts:↑Alistipes↑Eubacterium rectale↑Oscillospira guillermondii↑Parabacteroides↑Prevotella Grain: ↑Dialister	↑Faecalibacterium prausnitzii Grain: ↑species related to Clostridium difficileAnimal-based food:↑Collinsella ↑Ruminococcus gnavus↑Streptococcus bovis↑Streptococcus mitis↓Akkermansia muciniphila
Vitale et al. 2020	-29 overweight/obese participants-assigned to MD or control diet over an 8 week-interval	-16S rRNA region V3–V4	Significant increase in alpha diversity in the MD group	—	—	—	↑Akkermansia muciniphila↑Intestinimonas butyriciproducens↓Coprococcus comes↓Flavonifractor plautii↓Ruminococcus torques↓Streptococcus gallolyticus
Zhu et al. 2020	-10 healthy subjects consumed MD diet for 4 days, followed by a 4-day washout period, followed by 4-days of a fast-food diet	-16S rRNA V4 region	No significant effect	MD: ↑Firmicutes	MD:↑Lachnospiraceae familyFF: ↑Coriobacteria class ↑Deltaproteobacteria class↑Porphyromonadaceae family↑Rikenellaceae family↓Lachnosporaceae family	-MD:↑ButyricicoccusFF:↑Bilophila↑Collinsella↑Parabacteroides↓Butyricicoccus	—

Starting at the phyla level, Haro et al³² found that obese patients with metabolic syndrome were found to have decreased Bacteroidetes phylum at baseline which was increased following the MeD diet. Similarly, Van Soest et al,²¹ Ismael et al, and Illesecas et al showed an increase in Bacteroidetes phylum following the MeD.^21,30,34 Van Soest specifically showed a positive relationship between plant-based carbohydrates and the Bacteroidetes phylum and an inverse relationship between protein and fat. Zhu et al evaluated the MeD vs a fast food (FF) diet. They found that although the phylum Firmicutes was increased following the MeD,⁴⁰ there was no significant change found in F/B ratio, which was consistent with one additional study.^9,19,36 Similar to previous studies associating a high F/B ratio with inflammation/obesity, Zhu et al found F/B ratio to be negatively correlated with HDL-C, emphasizing a possible negative metabolic impact.^21,40

Genera was widely analyzed by the reviewed studies. Pagliali et al found a decrease in Parabacteroides following the MeD, while Zhu et al found an increase in this genus following a FF diet.^38,40 Parabacteroides has previously been associated with hypertension.⁴³ Ismael et al³⁰ quantified their results after varying time points, and found that after 4 weeks of MeD counseling, a higher ratio of Prevotella to Bacteriodes was detected. This P/B ratio has been examined in other studies such as Meslier et al⁴² who found that the MeD may improve insulin sensitivity in patients with high baseline levels of the generally inflammatory Bacteroides genus and lower levels of Prevotella genus. The anti-inflammatory Akkermansia genus was increased by the MeD in two studies.^34,36

Finally, at the most individualistic level there are species. Van Soest et al and Meslier et al found that animal product-rich foods resulted in a significant elevation in species associated with inflammation such as R gnavus, while plant-based food led to an increase in anti-inflammatory species such as F prausnitzii, emphasizing the importance of a vegetable centric diet, such as the MeD for gut health.^21,42 Tagliamonte also found a significant increase in F prausnitzii, in addition to Akkermansia muciniphila with the MeD which is decreased in T2DM, hypertension, obesity and IBD.⁴⁴ Vitale et al found similar results in their cohort of 29 overweight/obese individuals, with a significant increase in beneficial bacteria such as Akkermansia muciniphila, and a decrease in proinflammatory species. Specifically Akkermansia muciniphila is associated with increased production of butyrate, improving glucose metabolism and insulin sensitivity.³⁵ Results of Barber et al. study of 20 healthy similarly showed an increase in the butyrate-producing, colon protective species of Akkermensia genus.⁴¹

Discussion

Based on the dysbiosis found in psoriasis patients and the possible changes induced by the MeD on the gut microbiome, this may be one mechanism that the MeD may exert benefit for these patients. One way is by decreasing the F/B ratio by increasing Bacteroidetes as found in 4 studies and thus helping restore SCFA balance and promoting butyrate production.^21,30-33,45 This in turn could alleviate intestinal and systemic inflammation, having profound implications for psoriasis. Additional butyrate producers of the gut include species in the Akkermansia genus and Faecalibacterium prausnitzii, thus the MeD also promotes SCFA production through increasing these bacteria.^{21,31,32,34–37,42,44} This is of particular interest as the Akkermansia genus was found to be low in several studies on psoriasis and F prausnitzii or the Faacalibacterium genus as a whole was found to be reduced in two studies^12,13,15,19 Overall, the MeD has been suggested to alter the microbiota in several ways to promote an immune-regulated and anti-inflammatory state that would presumably be beneficial to psoriasis.

Cardiovascular disease, metabolic syndrome, and obesity are co-morbidities associated with psoriasis and also can be improved by the MeD.¹ The study by Haro et al suggests the MeD-induced microbiota changes may be more pronounced in those with obesity and/or metabolic syndrome. The MeD diet reduces the risk of cardiovascular disease, type 2 diabetes, and neurodegenerative diseases.^5,46 In Rinott et al,⁴⁵ the researchers employed the Green MED score to determine adherence to a plant-based diet. They discovered that higher adherence to the Green MED diet, which reduces animal-based food consumption even further than the traditional MeD, resulted in a more significant shift in the microbiome, as well as a reduction in markers linked to cardiometabolic disease. This is another argument for encouraging this dietary pattern in patients with psoriasis. By adopting a MeD, one has the potential to not only improve their skin disease but alter their microbiome in a way that improves overall health and wellness. This is especially pertinent to psoriasis patients, given their higher propensity to develop cardiovascular and metabolic co-morbidities.⁴⁷ Many studies proved the MeD diet’s positive effects as it pertain to metabolic syndrome by evaluating markers such as insulin sensitivity and hypertension.^30,42,45

The precise foods that impart beneficial effects within the MeD has also been studied.⁵ The MeD diet has a similar total fat intake to western diets, however more of that fat comes from omega-3s such as in fish and monounsaturated fatty acids such as olive oil vs saturated fats.⁵ There is evidence that this pattern of fat intake reduces LDL and triglycerides while raising beneficial HDL cholesterol, providing cardiovascular benefit.⁵ Furthermore, high omega-3 intake impacts prostaglandin metabolism by suppressing pro-inflammatory pathways, such has cycloxygenase-2 (COX-2), one of the targets of non-steroidal anti-inflammatory medications.⁴⁸ It is also important to note the lower intake of dairy products and land meats in the MeD than the western diet when considering its metabolic advantages. Furthermore, the high fiber in the MeD has a direct impact on the gut microbiome, positively influencing colonic production of butyrate. High fiber intake decreases risk of insulin resistance, another benefit.⁵

Notably, Dei-cas et al developed a Psoriasis-Microbiota Index (PMI) that could discriminate between psoriasis patients and controls with high sensitivity and specificity. This study is the first to propose a PMI with the ability to discriminate between psoriasis patients and age-sex-and BMI matched controls and between samples from communities of different continents by performing a meta-analysis.¹⁴ The successful development of a PMI suggests a signature dysbiosis of psoriasis patients Figure 2.

Figure 2.

The colon on the left represents the consequences of some of the proposed dysbiosis in psoriasis patients that the Mediterranean diet may alleviate. The colon on the right represents the relevant changes seen in the Mediterranean diet. The foods listed above the arrow are those eaten in large amounts in the Mediterranean diet, and those below the arrow are eaten sparingly.

However, an important consideration is the ability to adhere to the MeD. Studies have indicated that significant changes in the microbiome only occur with a high level of adherence over extended periods of time. This suggests that to fully reap the benefits of microbial changes, one should follow a high-adherence pattern. In Meslier et al⁴² the most significant changes in the microbiome were present during the high-adherence period, as defined by the MeD index. Pastor-Ibanez utilized a scoring system called MEDAS, with a score of 10 or higher being considered as high adherence. The study found significant results only in the high-adherence group, such as an increase in the presence of the fiber-degrading bacteria Burkholderiales and the anti-inflammatory bacteria Bifidobacterium and Lactobacillus.³⁹ Studies that showed no change in microbiota were shorter duration (4-7 days) with less time for the diet to be followed.^33,40 To achieve a meaningful, anti-inflammatory change in one’s microbiome, the stricter one adheres to the MeD and for a longer timeframe the greater likelihood to reap benefits. A limitation of the studies evaluating the microbiome in those following a MeD was the study populations were not patients with psoriasis. Furthermore, it is feasible that an individual who adheres closely to a diet may also adhere more closely to their prescribed medications, which themselves will impact psoriasis severity and have even been suggested to affect the gut microbiome.⁴⁹

Conclusion

The MeD has numerous health benefits including an association with lower psoriasis severity. A relationship between the gut microbiome and the MeD has been established. The changes induced by the MeD in the gut microbiome may possibly be beneficial for patients with psoriasis based on the dysbiosis patterns found in several studies, but this cannot be said with certainty as none of the MeD-microbiome studies were performed using psoriasis patients. Regardless, given the potential benefit for psoriasis and the overall state of health promoted by the MeD, there is little harm in recommending this diet to psoriasis patients who are interested in exploring if diet can impact their disease. Patients who do pursue a MeD should not stop their prescribed topical or systemic medicines.

Footnotes

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the T.B. is currently a principal investigator for studies being sponsored by Amgen, Castle, CorEvitas, Pfizer, and Regeneron. She has additional research funding from Novartis and Regeneron. She has served as an advisor for Abbvie, Arcutis, Boehringer-Ingelheim, Bristol Myers Squibb, Dermavant, Janssen, Leo, Lilly, Pfizer, Novartis, Sanofi, Sun, and UCB. W.L. has received research grant funding from Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio.

CME Credit

To claim CME credit: https://www.eeds.com/em/8102

Ethical Statement

ORCID iDs

Allison Kranyak

Kathryn Haran

Chandler Johnson

Wilson Liao

References

Parisi

Symmons

DPM

Griffiths

CEM

Ashcroft

. Global epidemiology of psoriasis: a systematic review of incid ence and prevalence. J Invest Dermatol. 2013;133(2):377-385. doi:10.1038/jid.2012.339.

AlQassimi

AlBrashdi

Galadari

Hashim

. Global burden of psoriasis – comparison of regional and global epidemiology, 1990 to 2017. Int J Dermatol. 2020;59(5):566-571. doi:10.1111/ijd.14864.

Ingkapairoj

Chularojanamontri

Chaiyabutr

Silpa-archa

Wongpraparut

Bunyaratavej

. Dietary habits and perceptions of psoriatic patients: Mediterranean versus Asian diets. J Dermatol Treat. 2022;33(4):2290-2296. doi:10.1080/09546634.2021.1959500.

Afifi

Danesh

Lee

, et al. Dietary behaviors in psoriasis: patient-reported outcomes from a U.S. National survey. Dermatol Ther. 2017;7(2):227-242. doi:10.1007/s13555-017-0183-4.

Romagnolo

Selmin

. Mediterranean diet and prevention of chronic diseases. Nutr Today. 2017;52(5):208. doi:10.1097/NT.0000000000000228.

Mazza

Ferro

Pujia

, et al. Mediterranean diet in healthy aging. J Nutr Health Aging. 2021;25(9):1076-1083. doi:10.1007/s12603-021-1675-6.

Barrea

Balato

Di Somma

, et al.

Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet?

J Transl Med. 2015;13:18. doi:10.1186/s12967-014-0372-1.

Phan

Touvier

Kesse-Guyot

, et al. Association between mediterranean anti-inflammatory dietary profile and severity of psoriasis. JAMA Dermatol. 2018;154(9):1017-1024. doi:10.1001/jamadermatol.2018.2127.

Armet

Deehan

O’Sullivan

, et al. Rethinking healthy eating in light of the gut microbiome. Cell Host Microbe. 2022;30(6):764-785. doi:10.1016/j.chom.2022.04.016.

10.

Walters

Martiny

JBH

. Alpha-, beta-, and gamma-diversity of bacteria varies across habitats. PLoS One. 2020;15(9):e0233872. doi:10.1371/journal.pone.0233872.

11.

Ikee

Sasaki

Yasuda

Fukazawa

. Chronic kidney disease, gut dysbiosis, and constipation: a burdensome triplet. Microorganisms. 2020;8(12):1862. doi:10.3390/microorganisms8121862.

12.

Scher

Ubeda

Artacho

, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015;67(1):128-139. doi:10.1002/art.38892.

13.

Schade

Mesa

Faria

, et al. The gut microbiota profile in psoriasis: a Brazilian case-control study. Lett Appl Microbiol. 2022;74(4):498-504. doi:10.1111/lam.13630.

14.

Dei-Cas

Giliberto

Luce

Dopazo

Penas-Steinhardt

. Metagenomic analysis of gut microbiota in non-treated plaque psoriasis patients stratified by disease severity: development of a new Psoriasis-Microbiome Index. Sci Rep. 2020;10(1):12754. doi:10.1038/s41598-020-69537-3.

15.

Chen

Tseng

Lai

Shieh

. Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients. Exp Dermatol. 2018;27(12):1336-1343. doi:10.1111/exd.13786.

16.

Codoñer

Ramírez-Bosca

Climent

, et al. Gut microbial composition in patients with psoriasis. Sci Rep. 2018;8(1):3812. doi:10.1038/s41598-018-22125-y.

17.

Hidalgo-Cantabrana

Gómez

Delgado

, et al. Gut microbiota dysbiosis in a cohort of patients with psoriasis. Br J Dermatol. 2019;181(6):1287-1295. doi:10.1111/bjd.17931.

18.

Shapiro

Cohen

Shalev

Uzan

Koren

Maharshak

. Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls. J Dermatol. 2019;46(7):595-603. doi:10.1111/1346-8138.14933.

19.

Tan

Zhao

Zhu

, et al. The Akkermansia muciniphila is a gut microbiota signature in psoriasis. Exp Dermatol. 2018;27(2):144-149. doi:10.1111/exd.13463.

20.

Chang

Yan

Singh

, et al. Multiomic analysis of the gut microbiome in psoriasis reveals distinct host‒microbe associations. JID Innov. 2022;2(3):100115. doi:10.1016/j.xjidi.2022.100115.

21.

van Soest

APM

Hermes

GDA

Berendsen

AAM

, et al. Associations between pro- and anti-inflammatory gastro-intestinal microbiota, diet, and cognitive functioning in Dutch healthy older adults: the NU-age study. Nutrients. 2020;12(11):3471. doi:10.3390/nu12113471.

22.

Verdam

Fuentes

De Jonge

, et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity: obese Gut Microbiota and Inflammation. Obesity. 2013;21(12):E607-E615. doi:10.1002/oby.20466.

23.

Portincasa

Bonfrate

Vacca

, et al. Gut microbiota and Short chain fatty acids: implications in glucose homeostasis. Int J Math Stat. 2022;23(3):1105. doi:10.3390/ijms23031105.

24.

Komaroff

. The microbiome and risk for obesity and diabetes. JAMA. 2017;317(4):355. doi:10.1001/jama.2016.20099.

25.

Zang

Liu

Mao

Zhu

Chen

Wei

. Causal associations between gut microbiota and psoriasis: a mendelian randomization study. Dermatol Ther. 2023;13(10). doi:10.1007/s13555-023-01007-w. Published online August 31.

26.

Zafar

Saier

. Gut Bacteroides species in health and disease. Gut Microb. 2021;13(1):1848158. doi:10.1080/19490976.2020.1848158.

27.

Precup

Vodnar

. Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: a comprehensive literature review. Br J Nutr. 2019;122(2):131-140. doi:10.1017/S0007114519000680.

28.

Lopez-Siles

Duncan

Garcia-Gil

Martinez-Medina

. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 2017;11(4):841-852. doi:10.1038/ismej.2016.176.

29.

Yeoh

Sun

LYT

, et al. Prevotella species in the human gut is primarily comprised of Prevotella copri, Prevotella stercorea and related lineages. Sci Rep. 2022;12(1):9055. doi:10.1038/s41598-022-12721-4.

30.

Ismael

Silvestre

Vasques

, et al.

A pilot study on the metabolic impact of mediterranean diet in type 2 diabetes: is gut microbiota the key?

Nutrients. 2021;13(4):1228. doi:10.3390/nu13041228.

31.

Ghosh

Rampelli

Jeffery

, et al. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut. 2020;69(7):1218-1228. doi:10.1136/gutjnl-2019-319654.

32.

Haro

García-Carpintero

Rangel-Zúñiga

, et al. Consumption of two healthy dietary patterns restored microbiota dysbiosis in obese patients with metabolic dysfunction. Mol Nutr Food Res. 2017;61(12):1700300. doi:10.1002/mnfr.201700300.

33.

Forteza

Bourdeau-Julien

Nguyen

, et al. Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized study. Sci Rep. 2022;12:8568. doi:10.1038/s41598-022-10757-0.

34.

Illescas

Rodríguez-Sosa

Gariboldi

. Mediterranean diet to prevent the development of colon diseases: a meta-analysis of gut microbiota studies. Nutrients. 2021;13(7):2234. doi:10.3390/nu13072234.

35.

Vitale

Giacco

Laiola

, et al.

Acute and chronic improvement in postprandial glucose metabolism by a diet resembling the traditional Mediterranean dietary pattern: can SCFAs play a role?

Clin Nutr. 2021;40(2):428-437. doi:10.1016/j.clnu.2020.05.025.

36.

Calabrese

Disciglio

Franco

, et al. A low glycemic index mediterranean diet combined with aerobic physical activity rearranges the gut microbiota signature in NAFLD patients. Nutrients. 2022;14(9):1773. doi:10.3390/nu14091773.

37.

Gómez-Pérez

Ruiz-Limón

Salas-Salvadó

, et al. Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis. Gut Microb. 15(1). 2223339. doi:10.1080/19490976.2023.2223339.

38.

Pagliai

Russo

Niccolai

, et al. Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: the CARDIVEG Study. Eur J Nutr. 2020;59(5):2011-2024. doi:10.1007/s00394-019-02050-0.

39.

Pastor-Ibáñez

Blanco-Heredia

Etcheverry

, et al. Adherence to a supplemented mediterranean diet drives changes in the gut microbiota of HIV-1-Infected individuals. Nutrients. 2021;13(4):1141. doi:10.3390/nu13041141.

40.

Zhu

Sawrey-Kubicek

Beals

, et al. Human gut microbiome composition and tryptophan metabolites were changed differently by fast food and Mediterranean diet in 4 days: a pilot study. Nutr Res. 2020;77:62-72. doi:10.1016/j.nutres.2020.03.005.

41.

Barber

Mego

Sabater

, et al. Differential effects of western and mediterranean-type diets on gut microbiota: a metagenomics and metabolomics approach. Nutrients. 2021;13(8):2638. doi:10.3390/nu13082638.

42.

Meslier

Laiola

Roager

, et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut. 2020;69(7):1258-1268. doi:10.1136/gutjnl-2019-320438.

43.

Yan

, et al. Alterations of the gut microbiome in hypertension. Front Cell Infect Microbiol. 2017;7:381. doi:10.3389/fcimb.2017.00381.

44.

Tagliamonte

Laiola

Ferracane

, et al. Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation. Eur J Nutr. 2021;60(7):3703-3716. doi:10.1007/s00394-021-02538-8.

45.

Rinott

Meir

Tsaban

, et al. The effects of the Green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: a randomized controlled trial. Genome Med. 2022;14:29. doi:10.1186/s13073-022-01015-z.

46.

Becerra-Tomás

Blanco Mejía

Viguiliouk

, et al. Mediterranean diet, cardiovascular disease and mortality in diabetes: a systematic review and meta-analysis of prospective cohort studies and randomized clinical trials. Crit Rev Food Sci Nutr. 2020;60(7):1207-1227. doi:10.1080/10408398.2019.1565281.

47.

Yamazaki

. Psoriasis: comorbidities. J Dermatol. 2021;48(6):732-740. doi:10.1111/1346-8138.15840.

48.

Jalili

Hekmatdoost

. Dietary ω-3 fatty acids and their influence on inflammation via Toll-like receptor pathways. Nutrition. 2021;85:111070. doi:10.1016/j.nut.2020.111070.

49.

Olejniczak-Staruch

Ciążyńska

Sobolewska-Sztychny

Narbutt

Skibińska

Lesiak

. Alterations of the skin and gut microbiome in psoriasis and psoriatic arthritis. Int J Mol Sci. 2021;22(8):3998. doi:10.3390/ijms22083998.

The Mediterranean Diet as a Potential Solution to the Gut Microbiome Dysbiosis in Psoriasis Patients

Abstract

Background

Methods

Results

Conclusion

Keywords

Introduction

Methods

Results

The Gut Microbiome in Patients With Psoriasis

The Gut Microbiome in Patients Consuming a Mediterranean Diet

Discussion

Conclusion

Footnotes

Declaration of conflicting interests

Funding

CME Credit

Ethical Statement

ORCID iDs

References